Cargando…

MALDI-MS: a Rapid and Reliable Method for Drug-to-Antibody Ratio Determination of Antibody-Drug Conjugates

BACKGROUND: It is believed that the loading value of anticancer drug conjugated to the monoclonal antibody, called drug-to-antibody ratio (DAR), is the main quality feature of antibody-drug conjugates. METHODS: In this study, matrix assisted laser desorption/ionization mass spectrometry was used to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abedi, Mehri, Ahangari Cohan, Reza, Mahboudi, Fereidoun, Shafiee Ardestani, Mehdi, Davami, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pasteur Institute of Iran 2019
Materias:	Full Length
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800535/ https://www.ncbi.nlm.nih.gov/pubmed/31104399 http://dx.doi.org/10.29252/ibj.23.6.395

Ejemplares similares

Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode
por: Karam, Saba, et al.
Publicado: (2021)

Woodchuck Hepatitis Virus Post-Transcriptional Regulation Element (WPRE) Promotes Anti-CD19 BiTE Expression in Expi293 Cells
por: Moazzami, Reza, et al.
Publicado: (2021)

Quantitative Proteomic Analysis of Cellular Responses to a Designed Amino Acid Feed in a Monoclonal Antibody Producing Chinese Hamster Ovary Cell Line
por: Torkashvand, Fatemeh, et al.
Publicado: (2018)

Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody
por: Torkashvand, Fatemeh, et al.
Publicado: (2015)

Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design
por: Ahmadi, Samira, et al.
Publicado: (2017)

Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells
por: Ebadat, Saeedeh, et al.
Publicado: (2017)

Novel G‐CSF conjugated anionic globular dendrimer: Preparation and biological activity assessment
por: Mousavi Motlagh, Seyed Shahaboddin, et al.
Publicado: (2021)

Effect of Peptone Feeding on Transient Gene Expression Process in CHO DG44
por: Davami, Fatemeh, et al.
Publicado: (2014)

Lamivudine‐conjugated and efavirenz‐loaded G2 dendrimers: Novel anti‐retroviral nano drug delivery systems
por: Pargoo, Esmaeel Mohammadi, et al.
Publicado: (2021)

Optimization of EnBase Fed-Batch Cultivation to Improve Soluble Fraction Ratio of α-Luffin Ribosome Inactivating Protein
por: Barkhordari, Farzaneh, et al.
Publicado: (2018)

Effects of Peptone Supplementation in Different Culture Media on Growth, Metabolic Pathway and Productivity of CHO DG44 Cells; a New Insight into Amino Acid Profiles
por: Davami, Fatemeh, et al.
Publicado: (2015)

AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics
por: Mohammadzadeh, Pardis, et al.
Publicado: (2017)

Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody–Drug Conjugate
por: Lee, Byeong ill, et al.
Publicado: (2020)

Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
por: Dugal-Tessier, Julien, et al.
Publicado: (2021)

Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates
por: Zhu, Xiaoyu, et al.
Publicado: (2020)

Introduction to Antibody-Drug Conjugates
por: Pettinato, Mark C.
Publicado: (2021)

ANTIBODY DRUG CONJUGATES (ADCS)
por: Terpos, E.
Publicado: (2023)

Fast Confirmation of Antibody Identity by MALDI-TOF MS Fingerprints
por: Tscheuschner, Georg, et al.
Publicado: (2020)

Anti Diabetic effect of CL 316,243 (A β3-Adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-α) Expression
por: Ghorbani, Masoud, et al.
Publicado: (2012)

Systematic LC/MS/MS Investigations for the IND-Enabling Extended Characterization of Antibody–Drug Conjugate Modifications
por: Linz, Thomas, et al.
Publicado: (2018)

The Epigenetic Regulation of Blinatumomab Gene Expression: Tumor Cell-dependent T cell Response against Lymphoma Cells and Cytotoxic Activity
por: Naddafi, Fatemeh, et al.
Publicado: (2019)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
por: Radocha, Jakub, et al.
Publicado: (2021)

Development of Streptococcus equisimilis Group G Mutant Strains with Ability to Produce Low Polydisperse and Low-Molecular-Weight Hyaluronic Acid
por: Jafari, Bahareh, et al.
Publicado: (2022)

Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
por: Donaghy, Heather
Publicado: (2016)

Affinity Based Nano-Magnetic Particles for Purification of Recombinant Proteins in Form of Inclusion Body
por: Seyedinkhorasani, Masoud, et al.
Publicado: (2020)

Antibody-Drug Conjugates in Bladder Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2018)

Antibody-Drug Conjugates: Possibilities and Challenges
por: Nejadmoghaddam, Mohammad-Reza, et al.
Publicado: (2019)

Acquired Resistance to Antibody-Drug Conjugates
por: Collins, Denis M., et al.
Publicado: (2019)

Antibody–Drug Conjugates for Cancer Therapy
por: Parslow, Adam C., et al.
Publicado: (2016)

Antibody–Drug Conjugates: The Last Decade
por: Joubert, Nicolas, et al.
Publicado: (2020)

Antibody–Drug Conjugates for Cancer Therapy
por: Hafeez, Umbreen, et al.
Publicado: (2020)

Antibody-drug conjugates: Present and future
por: Beck, Alain, et al.
Publicado: (2013)

Antibody–Drug Conjugate to Treat Meningiomas
por: Chen, Kai, et al.
Publicado: (2021)

Clinical Pharmacology of Antibody-Drug Conjugates
por: Mahmood, Iftekhar
Publicado: (2021)

Mechanisms of Resistance to Antibody–Drug Conjugates
por: Abelman, Rachel Occhiogrosso, et al.
Publicado: (2023)

Mechanisms of Resistance to Antibody-Drug Conjugates
por: Khoury, Rita, et al.
Publicado: (2023)

Improvement of Certolizumab Fab′ properties by PASylation technology
por: Mazaheri, Somayeh, et al.
Publicado: (2020)

Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control
por: Tang, Yubo, et al.
Publicado: (2017)

An antibody-free sample pretreatment method for osteopontin combined with MALDI-TOF MS/MS analysis
por: Zhou, Yuye, et al.
Publicado: (2019)

Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion
por: Wagner-Rousset, Elsa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_esq3r7k21sgmjul5eck0gr74ac